Source Pravda.Ru

FDA To Seal Yondelis' Fate

    The U.S. Food and Drug Administration applied for more data on Yondelis, a drug  developed by Johnson & Johnson (JNJ.N) and Spanish biotechnology firm Zeltia (ZEL.MC).

    It is approved for use in Europe, Russia and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U.S. FDA have granted orphan drug status to trabectedin for soft tissue sarcomas and ovarian cancer.

   On July 15, a panel of cancer experts recommended the FDA not approve the use of Yondelis, saying risks of heart and liver toxicity outweighed its limited ability to keep the disease in check.

   In a regulatory filing, Zeltia said the FDA had contacted J&J unit Centocor Ortho Biotech Products.

   "The agency has requested additional information, including overall survival data from the company's ongoing pivotal trial and additional clinical pharmacology studies," a Centocor statement included in the filing said.

     In a preliminary review released ahead of the meeting, FDA said it was considering whether to wait for more data on survival rates before making a decision on the drug, according to Forbes' report.

Comments
World War II still continues today for the purpose of Anglo-Saxon global domination
Five-year-old boy does 4,105 pushups in 2 hours 25 minutes
On the report of Human Rights Watch against the DPRK
Without INF Treaty, USA can destroy Russian nuclear weapons easily
Russia unveils nuclear-powered interstellar spaceship
Paris Peace Forum: A First Step but watch the Lobbies
Paris Peace Forum: A First Step but watch the Lobbies
Russia unveils nuclear-powered interstellar spaceship
Russia unveils nuclear-powered interstellar spaceship
Paris Peace Forum: A First Step but watch the Lobbies
Constantinople wants to break the spine of Orthodoxy
Russian PM threatens not to go to World Economic Forum in Davos
Russian PM threatens not to go to World Economic Forum in Davos
Russian officials celebrate 60th anti-Russian sanction
On the report of Human Rights Watch against the DPRK
Moving inexorably towards war
The difference between Polish and Ukrainian nationalism is plain to see
Paris Peace Forum: A First Step but watch the Lobbies
The difference between Polish and Ukrainian nationalism is plain to see
The difference between Polish and Ukrainian nationalism is plain to see
Russia close to recognising Donetsk and Luhansk republics after Donbass elections